Antibiotics May Prevent Chemoresistance in Metastatic Pancreatic Cancer
Antibiotics may prevent bacteria-mediated chemoresistance in patients with metastatic pancreatic cancer, a new study suggests.
Pancreatic Cancer News
PANCREATIC CANCER ADVISOR
Pancreatic Cancer News
Ulenistamab Fast Tracked for Advanced/Metastatic Pancreatic Cancer
Ulenistamab targets PAUF, a tumor-specific protein that is overexpressed in pancreatic cancer cells.
Ramucirumab Does Not Improve Upon Chemotherapy in Advanced Pancreatic Cancer
Adding ramucirumab to first-line chemotherapy does not improve outcomes in patients with advanced pancreatic ductal adenocarcinoma, a study suggests.
Cancer Patients in Nursing Homes More Likely to Receive Aggressive End-of-Life Care
Cancer patients living in nursing homes are more likely to receive aggressive end-of-life care and die in the hospital, a study suggests.
Pancreatic Cancer Trials Don’t Adhere to Eligibility Criteria Guidelines
Overall compliance with eligibility criteria guidelines is low for pancreatic cancer trials, a recent study suggests.
Incidence of Pancreatic Cancer Increasing in Younger Women
In younger adults, there was a greater increase in the incidence of pancreatic cancer among women than among men.
Cancer Mortality Rates Increased for Older Patients With Diabetes
People with type 2 diabetes have an increased risk of death from colorectal, pancreatic, liver, and endometrial cancer, compared with the general population.
System May Enable Precision Medicine in Cancer Care
A decision support system called GI TARGET may help integrate precision medicine into routine care for patients with gastrointestinal cancer, according to researchers.
NAPOLI-3 Results Support NALIRIFOX for Metastatic Pancreatic Cancer
NALIRIFOX outperformed treatment with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer in the NAPOLI-3 trial.
ACS Report Shows Prostate Cancer on the Rise, Cervical Cancer on the Decline
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
Dihydropyridine Calcium Channel Blockers Do Not Increase Risk of Pancreatic Cancer, Study Suggests
New research suggests that, contrary to previous reports, dihydropyridine calcium channel blockers do not increase the risk of pancreatic cancer.
No Benefit Seen With Extended S-1 Chemo After Pancreatic Cancer Resection
Extending adjuvant S-1 chemotherapy beyond 6 months after resection of pancreatic ductal adenocarcinoma does not improve outcomes, a real-world study suggests.
Xeloda Labeling Updated Under FDA’s New Program for Older Oncology Drugs
Project Renewal is an Oncology Center of Excellence initiative that aims to update the labeling information for certain older oncology drugs.
Adults Lack Knowledge About Signs of Pancreatic Cancer
In a survey of more than 1000 adults, 83% said they are unaware of the signs or symptoms of pancreatic cancer.
Medicine vs Food: The Patient Care Dilemma of Financial Toxicity
Physicians are calling on colleagues to bring up the cost of care and its potential impact when discussing treatment options with patients.
Bariatric Surgery May Reduce Risk of Pancreatic Cancer in Patients With Obesity
Bariatric surgery may reduce the risk of pancreatic cancer in patients with obesity who are younger than 50 years of age, a study suggests.
MYC Inhibitor Can Stave Off Progression in Patients With Advanced Solid Tumors
In a first-in-human trial of patients with solid tumors, a MYC inhibitor appeared tolerable and enabled nearly half of evaluable patients to maintain stable disease.
Radiation to Celiac Plexus Reduces Pancreatic Cancer-Associated Pain
Delivery of radiation to the celiac plexus can decrease pain and opioid use among patients with pancreatic cancer, a phase 2 study suggests.
PCOS Associated With Increased Risk of Pancreatic Cancer
A diagnosis of PCOS was associated with a 1.9-fold higher risk of pancreatic cancer in a case-control study.
Improving Cancer Care for Transgender Patients
Transgender patients with cancer may be less likely to receive adequate care and have worse outcomes than their cisgender counterparts.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Pancreatic Cancer
Loading... 
Loading...